Based on our analysis, one such DDR deficiency could be impaired NER due to downregulation of GTF2H1 expression, rendering SWI/SNF cancers more sensitive to DNA damaging chemotherapeutic drugs such as cisplatin (Fig. 7). The gene discussed is SMARCA1; the disease is cancer.